Get WisER+ Now

BeWisER+ About Breast Cancer helps ER+ breast cancer survivors who are on anti-estrogen therapy learn more about treatment options, related side effects, likelihood of the cancer coming back, and new information and tests to help personalize your treatment plan.

Whether you’re an early stage (stage I & II) ER+ breast cancer patient or survivor, understanding the information available to you and your doctor allows you to work together to better plan your treatment pathway.

Be wiser. Talk to your doctor.

Learn How

What’s new with BeWisER+?

Check out BeWisER+’s Raise Your 5! Learn how important the number 5 is in ER+ breast cancer and share your story to show your support.

What’s next for you?

At the 5 year mark, many survivors struggle with one question: “Should I continue with anti-estrogen treatment for an additional 5 years?” Did you know there is a test for early-stage, ER+ breast cancer that can help you and your doctor make the right choice for you?

Be wiser.

Learn More

Recent Activity

Today at #SABCS: KOLs discussed the role of genomic tests like Breast Cancer Index in deciding whether or not to extend anti-estrogen therapy beyond 5 years in light of the recent data presented at the conference. Learn more about Breast Cancer Index: www.answersbeyond5.com/ ... See MoreSee Less

Attending #SABCS? Come to today's panel presentation on extended anti-estrogen therapy to see how KOLs apply data to clinical decision-making 12pm at the product theater hall on the exhibit floor.
#SABCS16
... See MoreSee Less

Understanding your personal risk of recurrence after year 5 is important in determining your treatment plan. In a study presented at #SABCS, 36% of patients classified as low risk based on clinical factors were identified by Breast Cancer Index as high risk. What's your risk? Get informed. ... See MoreSee Less

BeWisER+ About Breast Cancer shared AnswersBeyond5's photo. ... See MoreSee Less